Skip to main content
Top
Published in: BMC Geriatrics 1/2019

Open Access 01-12-2019 | Parkinson's Disease | Research article

Trends in the incidence and prevalence of Parkinson’s disease in Korea: a nationwide, population-based study

Authors: Joo-Hyun Park, Do-Hoon Kim, Do-Young Kwon, Moonyoung Choi, Shinhye Kim, Jin-Hyung Jung, Kyungdo Han, Yong-Gyu Park

Published in: BMC Geriatrics | Issue 1/2019

Login to get access

Abstract

Background

The lack of adequate and detailed epidemiological data of Parkinson’s disease (PD), especially in Asia, is a barrier to future disease burdens and the prospect of effective public health plans. This study aimed to investigate temporal trends in the incidence and prevalence of PD in South Korea from 2010 to 2015, based on uniform diagnostic criteria.

Methods

This study examined all PD patients registered in a South Korean national registry database of more than 50 million individuals. We analyzed the incidence and prevalence of PD according to age, gender, and region.

Results

The annual incidence of PD was between 22.4–27.8 cases per 100,000 individuals. During the 6-year study period, there were 73,726 new PD patients, 42.3% of whom were men. The standardized incidence of PD increased over time in men but remained constant in women until 2013 but began to increase in 2014. The female-to-male ratio in the incidence of PD was 1.4:1 while the female-to-male ratio in the prevalence of PD was 1.6:1. The age- and gender-standardized prevalence of PD increased from 115.9 cases per 100,000 individuals in 2010 to 139.8 cases per 100,000 individuals in 2015. From 2014, the incidence and prevalence of PD peaked in individuals aged between 80 and 89 years in both men and women. Regional analysis also showed an increased prevalence of PD in all regions of Korea.

Conclusions

The incidence and prevalence of PD in Korea were higher in women and increased gradually from 2010 to 2015. The findings may contribute to epidemiological studies of PD in Asia, and may provide clues on risk factors for PD.
Literature
1.
go back to reference United Nations, Department of Economic and Social Affiairs, Population Division. World population prospects: the 2017 revision, key fings and advance tables. New York: United Nations; 2017. United Nations, Department of Economic and Social Affiairs, Population Division. World population prospects: the 2017 revision, key fings and advance tables. New York: United Nations; 2017.
2.
go back to reference de Lau LM, Breteler MM. Epidemiology of Parkinson’s disease. Lancet Neurol. 2006;5(6):525–35.CrossRef de Lau LM, Breteler MM. Epidemiology of Parkinson’s disease. Lancet Neurol. 2006;5(6):525–35.CrossRef
3.
go back to reference Kalia LV, Lang AE. Parkinson’s disease. Lancet. 2015;386(9996):896–912.CrossRef Kalia LV, Lang AE. Parkinson’s disease. Lancet. 2015;386(9996):896–912.CrossRef
4.
go back to reference Rubenstein LM, DeLeo A, Chrischilles EA. Economic and health-related quality of life considerations of new therapies in Parkinson’s disease. Pharmacoeconomics. 2001;19(7):729–52.CrossRef Rubenstein LM, DeLeo A, Chrischilles EA. Economic and health-related quality of life considerations of new therapies in Parkinson’s disease. Pharmacoeconomics. 2001;19(7):729–52.CrossRef
5.
go back to reference Dowding CH, Shenton CL, Salek SS. A review of the health-related quality of life and economic impact of Parkinson’s disease. Drugs Aging. 2006;23(9):693–721.CrossRef Dowding CH, Shenton CL, Salek SS. A review of the health-related quality of life and economic impact of Parkinson’s disease. Drugs Aging. 2006;23(9):693–721.CrossRef
6.
go back to reference Winter Y, von Campenhausen S, Brozova H, Skoupa J, Reese JP, Botzel K, Eggert K, Oertel WH, Dodel R, Ruzicka E. Costs of Parkinson’s disease in eastern Europe: a Czech cohort study. Parkinsonism Relat Disord. 2010;16(1):51–6.CrossRef Winter Y, von Campenhausen S, Brozova H, Skoupa J, Reese JP, Botzel K, Eggert K, Oertel WH, Dodel R, Ruzicka E. Costs of Parkinson’s disease in eastern Europe: a Czech cohort study. Parkinsonism Relat Disord. 2010;16(1):51–6.CrossRef
7.
go back to reference Kudlicka A, Clare L, Hindle JV. Quality of life, health status and caregiver burden in Parkinson’s disease: relationship to executive functioning. Int J Geriatr Psychiatry. 2014;29(1):68–76.CrossRef Kudlicka A, Clare L, Hindle JV. Quality of life, health status and caregiver burden in Parkinson’s disease: relationship to executive functioning. Int J Geriatr Psychiatry. 2014;29(1):68–76.CrossRef
8.
go back to reference Muangpaisan W, Hori H, Brayne C. Systematic review of the prevalence and incidence of Parkinson’s disease in Asia. J Epidemiol. 2009;19(6):281–93.CrossRef Muangpaisan W, Hori H, Brayne C. Systematic review of the prevalence and incidence of Parkinson’s disease in Asia. J Epidemiol. 2009;19(6):281–93.CrossRef
9.
go back to reference Savica R, Grossardt BR, Bower JH, Ahlskog JE, Rocca WA. Time trends in the incidence of Parkinson disease. JAMA Neurol. 2016;73(8):981–9.CrossRef Savica R, Grossardt BR, Bower JH, Ahlskog JE, Rocca WA. Time trends in the incidence of Parkinson disease. JAMA Neurol. 2016;73(8):981–9.CrossRef
10.
go back to reference Liu CC, Li CY, Lee PC, Sun Y. Variations in incidence and prevalence of Parkinson’s disease in Taiwan: a population-based nationwide study. Parkinsons Dis. 2016;2016:8756359.PubMedPubMedCentral Liu CC, Li CY, Lee PC, Sun Y. Variations in incidence and prevalence of Parkinson’s disease in Taiwan: a population-based nationwide study. Parkinsons Dis. 2016;2016:8756359.PubMedPubMedCentral
11.
go back to reference Akushevich I, Kravchenko J, Ukraintseva S, Arbeev K, Yashin AI. Time trends of incidence of age-associated diseases in the US elderly population: Medicare-based analysis. Age Ageing. 2013;42(4):494–500.CrossRef Akushevich I, Kravchenko J, Ukraintseva S, Arbeev K, Yashin AI. Time trends of incidence of age-associated diseases in the US elderly population: Medicare-based analysis. Age Ageing. 2013;42(4):494–500.CrossRef
12.
go back to reference Darweesh SK, Koudstaal PJ, Stricker BH, Hofman A, Ikram MA. Trends in the incidence of Parkinson disease in the general population: the Rotterdam study. Am J Epidemiol. 2016;183(11):1018–26.CrossRef Darweesh SK, Koudstaal PJ, Stricker BH, Hofman A, Ikram MA. Trends in the incidence of Parkinson disease in the general population: the Rotterdam study. Am J Epidemiol. 2016;183(11):1018–26.CrossRef
13.
go back to reference Horsfall L, Petersen I, Walters K, Schrag A. Time trends in incidence of Parkinson’s disease diagnosis in UK primary care. J Neurol. 2013;260(5):1351–7.CrossRef Horsfall L, Petersen I, Walters K, Schrag A. Time trends in incidence of Parkinson’s disease diagnosis in UK primary care. J Neurol. 2013;260(5):1351–7.CrossRef
14.
go back to reference Liu WM, Wu RM, Lin JW, Liu YC, Chang CH, Lin CH. Time trends in the prevalence and incidence of Parkinson’s disease in Taiwan: a nationwide, population-based study. J Formos Med Assoc. 2016;115(7):531–8.CrossRef Liu WM, Wu RM, Lin JW, Liu YC, Chang CH, Lin CH. Time trends in the prevalence and incidence of Parkinson’s disease in Taiwan: a nationwide, population-based study. J Formos Med Assoc. 2016;115(7):531–8.CrossRef
15.
go back to reference de Rijk MC, Launer LJ, Berger K, Breteler MM, Dartigues JF, Baldereschi M, Fratiglioni L, Lobo A, Martinez-Lage J, Trenkwalder C, et al. Prevalence of Parkinson’s disease in Europe: a collaborative study of population-based cohorts. Neurologic diseases in the elderly research group. Neurology. 2000;54(11 Suppl 5):S21–3.PubMed de Rijk MC, Launer LJ, Berger K, Breteler MM, Dartigues JF, Baldereschi M, Fratiglioni L, Lobo A, Martinez-Lage J, Trenkwalder C, et al. Prevalence of Parkinson’s disease in Europe: a collaborative study of population-based cohorts. Neurologic diseases in the elderly research group. Neurology. 2000;54(11 Suppl 5):S21–3.PubMed
16.
go back to reference Blin P, Dureau-Pournin C, Foubert-Samier A, Grolleau A, Corbillon E, Jove J, Lassalle R, Robinson P, Poutignat N, Droz-Perroteau C, et al. Parkinson’s disease incidence and prevalence assessment in France using the national healthcare insurance database. Eur J Neurol. 2015;22(3):464–71.CrossRef Blin P, Dureau-Pournin C, Foubert-Samier A, Grolleau A, Corbillon E, Jove J, Lassalle R, Robinson P, Poutignat N, Droz-Perroteau C, et al. Parkinson’s disease incidence and prevalence assessment in France using the national healthcare insurance database. Eur J Neurol. 2015;22(3):464–71.CrossRef
17.
go back to reference Evans JR, Cummins G, Breen DP, Foltynie T, Mason SL, Brayne CE, Williams-Gray CH, Barker RA. Comparative epidemiology of incident Parkinson’s disease in Cambridgeshire, UK. J Neurol Neurosurg Psychiatry. 2016;87(9):1034–6.CrossRef Evans JR, Cummins G, Breen DP, Foltynie T, Mason SL, Brayne CE, Williams-Gray CH, Barker RA. Comparative epidemiology of incident Parkinson’s disease in Cambridgeshire, UK. J Neurol Neurosurg Psychiatry. 2016;87(9):1034–6.CrossRef
18.
go back to reference Benito-Leon J, Bermejo-Pareja F, Rodriguez J, Molina JA, Gabriel R, Morales JM, Neurological Disorders in Central Spain Study G. Prevalence of PD and other types of parkinsonism in three elderly populations of central Spain. Mov Disord. 2003;18(3):267–74.CrossRef Benito-Leon J, Bermejo-Pareja F, Rodriguez J, Molina JA, Gabriel R, Morales JM, Neurological Disorders in Central Spain Study G. Prevalence of PD and other types of parkinsonism in three elderly populations of central Spain. Mov Disord. 2003;18(3):267–74.CrossRef
19.
go back to reference Kim L, Kim JA, Kim S. A guide for the utilization of health insurance review and assessment service national patient samples. Epidemiol Health. 2014;36:e2014008.CrossRef Kim L, Kim JA, Kim S. A guide for the utilization of health insurance review and assessment service national patient samples. Epidemiol Health. 2014;36:e2014008.CrossRef
20.
go back to reference Schrag A, Hovris A, Morley D, Quinn N, Jahanshahi M. Young-versus older-onset Parkinson’s disease: impact of disease and psychosocial consequences. Mov Disord. 2003;18(11):1250–6.CrossRef Schrag A, Hovris A, Morley D, Quinn N, Jahanshahi M. Young-versus older-onset Parkinson’s disease: impact of disease and psychosocial consequences. Mov Disord. 2003;18(11):1250–6.CrossRef
21.
go back to reference Kieburtz K, Wunderle KB. Parkinson’s disease: evidence for environmental risk factors. Mov Disord. 2013;28(1):8–13.CrossRef Kieburtz K, Wunderle KB. Parkinson’s disease: evidence for environmental risk factors. Mov Disord. 2013;28(1):8–13.CrossRef
22.
go back to reference Yamawaki M, Kusumi M, Kowa H, Nakashima K. Changes in prevalence and incidence of Parkinson’s disease in Japan during a quarter of a century. Neuroepidemiology. 2009;32(4):263–9.CrossRef Yamawaki M, Kusumi M, Kowa H, Nakashima K. Changes in prevalence and incidence of Parkinson’s disease in Japan during a quarter of a century. Neuroepidemiology. 2009;32(4):263–9.CrossRef
23.
go back to reference Van Den Eeden SK, Tanner CM, Bernstein AL, Fross RD, Leimpeter A, Bloch DA, Nelson LM. Incidence of Parkinson’s disease: variation by age, gender, and race/ethnicity. Am J Epidemiol. 2003;157(11):1015–22.CrossRef Van Den Eeden SK, Tanner CM, Bernstein AL, Fross RD, Leimpeter A, Bloch DA, Nelson LM. Incidence of Parkinson’s disease: variation by age, gender, and race/ethnicity. Am J Epidemiol. 2003;157(11):1015–22.CrossRef
24.
go back to reference Harada H, Nishikawa S, Takahashi K. Epidemiology of Parkinson’s disease in a Japanese city. Arch Neurol. 1983;40(3):151–4.CrossRef Harada H, Nishikawa S, Takahashi K. Epidemiology of Parkinson’s disease in a Japanese city. Arch Neurol. 1983;40(3):151–4.CrossRef
25.
go back to reference Kusumi M, Nakashima K, Harada H, Nakayama H, Takahashi K. Epidemiology of Parkinson’s disease in Yonago City, Japan: comparison with a study carried out 12 years ago. Neuroepidemiology. 1996;15(4):201–7.CrossRef Kusumi M, Nakashima K, Harada H, Nakayama H, Takahashi K. Epidemiology of Parkinson’s disease in Yonago City, Japan: comparison with a study carried out 12 years ago. Neuroepidemiology. 1996;15(4):201–7.CrossRef
26.
go back to reference Moriwaka F, Tashiro K, Itoh K, Honma S, Okumura H, Kikuchi S, Hamada T, Kaneko S, Kurokawa Y. Prevalence of Parkinson’s disease in Hokkaido, the northernmost island of Japan. Intern Med. 1996;35(4):276–9.CrossRef Moriwaka F, Tashiro K, Itoh K, Honma S, Okumura H, Kikuchi S, Hamada T, Kaneko S, Kurokawa Y. Prevalence of Parkinson’s disease in Hokkaido, the northernmost island of Japan. Intern Med. 1996;35(4):276–9.CrossRef
27.
go back to reference Kimura H, Kurimura M, Wada M, Kawanami T, Kurita K, Suzuki Y, Katagiri T, Daimon M, Kayama T, Kato T. Female preponderance of Parkinson’s disease in Japan. Neuroepidemiology. 2002;21(6):292–6.CrossRef Kimura H, Kurimura M, Wada M, Kawanami T, Kurita K, Suzuki Y, Katagiri T, Daimon M, Kayama T, Kato T. Female preponderance of Parkinson’s disease in Japan. Neuroepidemiology. 2002;21(6):292–6.CrossRef
28.
go back to reference Okada K, Kobayashi S, Tsunematsu T. Prevalence of Parkinson’s disease in Izumo City, Japan. Gerontology. 1990;36(5–6):340–4.CrossRef Okada K, Kobayashi S, Tsunematsu T. Prevalence of Parkinson’s disease in Izumo City, Japan. Gerontology. 1990;36(5–6):340–4.CrossRef
29.
go back to reference Morioka S, Sakata K, Yoshida S, Nakai E, Shiba M, Yoshimura N, Hashimoto T. Incidence of Parkinson disease in Wakayama, Japan. J Epidemiol. 2002;12(6):403–7.CrossRef Morioka S, Sakata K, Yoshida S, Nakai E, Shiba M, Yoshimura N, Hashimoto T. Incidence of Parkinson disease in Wakayama, Japan. J Epidemiol. 2002;12(6):403–7.CrossRef
30.
go back to reference Saunders-Pullman R. Estrogens and Parkinson disease: neuroprotective, symptomatic, neither, or both? Endocrine. 2003;21(1):81–7.CrossRef Saunders-Pullman R. Estrogens and Parkinson disease: neuroprotective, symptomatic, neither, or both? Endocrine. 2003;21(1):81–7.CrossRef
31.
go back to reference Park SJ, Kim HJ, Park H, Hann HJ, Kim KH, Han S, Kim Y, Ahn HS. Incidence, prevalence, mortality and causes of death in Takayasu arteritis in Korea - a nationwide, population-based study. Int J Cardiol. 2017;235:100–4.CrossRef Park SJ, Kim HJ, Park H, Hann HJ, Kim KH, Han S, Kim Y, Ahn HS. Incidence, prevalence, mortality and causes of death in Takayasu arteritis in Korea - a nationwide, population-based study. Int J Cardiol. 2017;235:100–4.CrossRef
32.
go back to reference Kim HJ, Hann HJ, Hong SN, Kim KH, Ahn IM, Song JY, Lee SH, Ahn HS. Incidence and natural course of inflammatory bowel disease in Korea, 2006-2012: a nationwide population-based study. Inflamm Bowel Dis. 2015;21(3):623–30.CrossRef Kim HJ, Hann HJ, Hong SN, Kim KH, Ahn IM, Song JY, Lee SH, Ahn HS. Incidence and natural course of inflammatory bowel disease in Korea, 2006-2012: a nationwide population-based study. Inflamm Bowel Dis. 2015;21(3):623–30.CrossRef
33.
go back to reference Dickson DW, Braak H, Duda JE, Duyckaerts C, Gasser T, Halliday GM, Hardy J, Leverenz JB, Del Tredici K, Wszolek ZK, et al. Neuropathological assessment of Parkinson’s disease: refining the diagnostic criteria. Lancet Neurol. 2009;8(12):1150–7.CrossRef Dickson DW, Braak H, Duda JE, Duyckaerts C, Gasser T, Halliday GM, Hardy J, Leverenz JB, Del Tredici K, Wszolek ZK, et al. Neuropathological assessment of Parkinson’s disease: refining the diagnostic criteria. Lancet Neurol. 2009;8(12):1150–7.CrossRef
34.
go back to reference Hughes AJ, Daniel SE, Lees AJ. Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease. Neurology. 2001;57(8):1497–9.CrossRef Hughes AJ, Daniel SE, Lees AJ. Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease. Neurology. 2001;57(8):1497–9.CrossRef
35.
go back to reference Anderson DW, Schoenberg BS, Haerer AF. Prevalence surveys of neurologic disorders: methodologic implications of the Copiah County study. J Clin Epidemiol. 1988;41(4):339–45.CrossRef Anderson DW, Schoenberg BS, Haerer AF. Prevalence surveys of neurologic disorders: methodologic implications of the Copiah County study. J Clin Epidemiol. 1988;41(4):339–45.CrossRef
36.
go back to reference Bermejo F, Gabriel R, Vega S, Morales JM, Rocca WA, Anderson DW, Neurological Disorders in Central Spain Study G. Problems and issues with door-to-door, two-phase surveys: an illustration from central Spain. Neuroepidemiology. 2001;20(4):225–31.CrossRef Bermejo F, Gabriel R, Vega S, Morales JM, Rocca WA, Anderson DW, Neurological Disorders in Central Spain Study G. Problems and issues with door-to-door, two-phase surveys: an illustration from central Spain. Neuroepidemiology. 2001;20(4):225–31.CrossRef
Metadata
Title
Trends in the incidence and prevalence of Parkinson’s disease in Korea: a nationwide, population-based study
Authors
Joo-Hyun Park
Do-Hoon Kim
Do-Young Kwon
Moonyoung Choi
Shinhye Kim
Jin-Hyung Jung
Kyungdo Han
Yong-Gyu Park
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Geriatrics / Issue 1/2019
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/s12877-019-1332-7

Other articles of this Issue 1/2019

BMC Geriatrics 1/2019 Go to the issue